1. Home
  2. ATLN vs UROY Comparison

ATLN vs UROY Comparison

Compare ATLN & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLN
  • UROY
  • Stock Information
  • Founded
  • ATLN N/A
  • UROY 2017
  • Country
  • ATLN
  • UROY Canada
  • Employees
  • ATLN 7
  • UROY N/A
  • Industry
  • ATLN
  • UROY
  • Sector
  • ATLN
  • UROY
  • Exchange
  • ATLN NYSE
  • UROY Nasdaq
  • Market Cap
  • ATLN 248.2M
  • UROY 294.0M
  • IPO Year
  • ATLN N/A
  • UROY N/A
  • Fundamental
  • Price
  • ATLN $5.32
  • UROY $2.14
  • Analyst Decision
  • ATLN
  • UROY Strong Buy
  • Analyst Count
  • ATLN 0
  • UROY 2
  • Target Price
  • ATLN N/A
  • UROY $5.60
  • AVG Volume (30 Days)
  • ATLN N/A
  • UROY 2.3M
  • Earning Date
  • ATLN N/A
  • UROY 12-12-2024
  • Dividend Yield
  • ATLN N/A
  • UROY N/A
  • EPS Growth
  • ATLN N/A
  • UROY 256.61
  • EPS
  • ATLN N/A
  • UROY 0.03
  • Revenue
  • ATLN N/A
  • UROY $27,478,292.00
  • Revenue This Year
  • ATLN N/A
  • UROY N/A
  • Revenue Next Year
  • ATLN N/A
  • UROY $72.53
  • P/E Ratio
  • ATLN N/A
  • UROY $81.37
  • Revenue Growth
  • ATLN N/A
  • UROY 31.26
  • 52 Week Low
  • ATLN N/A
  • UROY $1.86
  • 52 Week High
  • ATLN N/A
  • UROY $3.76
  • Technical
  • Relative Strength Index (RSI)
  • ATLN N/A
  • UROY 33.28
  • Support Level
  • ATLN N/A
  • UROY $2.15
  • Resistance Level
  • ATLN N/A
  • UROY $2.70
  • Average True Range (ATR)
  • ATLN 0.00
  • UROY 0.14
  • MACD
  • ATLN 0.00
  • UROY -0.03
  • Stochastic Oscillator
  • ATLN 0.00
  • UROY 8.18

About ATLN ATLANTIC INTERNATIONAL CORP

Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.

About UROY Uranium Royalty Corp.

Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.

Share on Social Networks: